COVID-19, Renal Transplant Infection
Conditions
Brief summary
Post-transplant patients with COVID-19 infection who attended Shenzhen No. 3 Hospital from December 2022 to February 2023, and enrolled the general population with COVID-19 infection who were hospitalized during the same period, matched by age and gender.
Detailed description
Data collection：Age, BMI, underlying comorbidities and other basic information were collected retrospectively from the two groups. The medical records were used to collect information about the patients' new coronavirus infection, such as the time of onset of symptoms, time of diagnosis, time of conversion and common symptoms such as fever, cough, nasal congestion and runny nose, muscle aches and pains.To compare the differences of the diagnosis and treatment of KTRs and the general population infected with Omicron
Interventions
OTHERTreatment plan
Patients with different diagnoses will get different treatment options
Sponsors
Shenzhen Third People's Hospital
Tianjin First Central Hospital
Study design
Observational model
CASE_CONTROL
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes
Inclusion criteria
Confirmed novel coronavirus infection between December 2022 to February 2023,
Exclusion criteria
Age less than 18; failure of the transplanted kidney before the new coronavirus infection; exclusion of oral immunosuppressed and other types of organ transplant recipients from the non-renal transplant population
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| ICU admission or death | through study completion, an average of 1 month | patients have ICU admission or death |
Countries
China
Contacts
Primary ContactYingxin Fu, MD
Backup ContactJianyong pan, MD
Outcome results
None listed